Aclarion, Inc. ACONW

Competitive advantage analysis · healthcare

Corporate Default
Overall moat score
14/100
Weak

About Aclarion, Inc.

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially … Full ACONW analysis →

Competitive advantage assessment

Key strengths

  • Strong Liquidity Buffer Liquidity position is strong (score 1.00), providing operational cushion.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 8.1th percentile with high volatility suggests weak pricing power or commoditized products.
  • ROIC Below WACC or Peers ROIC at 22.4th percentile suggests inefficient capital deployment.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
6

Where ACONW ranks in Health Information Services

Aclarion, Inc. ranks #62 of 68 scored companies in Health Information Services by moat score — the top 91%. The widest moat in the group is Veeva Systems Inc. (VEEV) at 88/100.

Moat scores for companies ranked near ACONW in Health Information Services
# Company Moat score Rating
58 Bullfrog AI Holdings, Inc. BFRG 17/100 Weak
59 MSP Recovery, Inc. MSPR 17/100 Weak
60 MSP Recovery, Inc. MSPRW 17/100 Weak
61 Aclarion, Inc. ACON 15/100 Weak
62 Aclarion, Inc. ACONW 14/100 Weak
63 Heartbeam, Inc. BEAT 14/100 Weak
64 Accolade, Inc. ACCD 0/100 Weak
65 MultiPlan Corporation MPLN 0/100 Weak
66 Ontrak, Inc. OTRK 0/100 Weak

See every General Corporate company ranked by moat score →

How ACONW scores on the Corporate Default defenses

Pricing Power

Score 6 · 20% of the moat score

Pricing power is the ability to raise prices without losing volume.

Cost Advantage

Score 3 · 15% of the moat score

A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.

Customer Stickiness

Score 15 · 15% of the moat score

Stickiness is what makes revenue repeat without being re-won every year.

Capital Efficiency

Score 8 · 18% of the moat score

Capital efficiency asks what the company earns on the money tied up in the business.

Resilience

Score 47 · 17% of the moat score

Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.

Scale & Market Position

Score 7 · 15% of the moat score

Scale matters only when it converts into economics.

How each Corporate Default defense is measured, in full →

Understanding ACONW's moat

What is Aclarion, Inc.'s moat score?

Aclarion, Inc. (ACONW) scores 14 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as weak. It ranks #62 of 68 scored companies in Health Information Services, the top 91%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 67 companies in Health Information Services. Its strongest defense is Resilience (47/100) and its weakest is Cost Advantage (3/100).

How does Aclarion, Inc. compare with other Health Information Services companies?

Aclarion, Inc. ranks #62 of 68 scored companies in Health Information Services by moat score. The widest moat in Health Information Services is Veeva Systems Inc. (VEEV) at 88/100. The companies ranked closest are Aclarion, Inc. (ACON) at 15 just above it and Heartbeam, Inc. (BEAT) at 14 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 67 companies in Health Information Services. The defenses are then weighted to produce the overall score out of 100.

Why is Aclarion, Inc. scored with the Corporate Default template?

Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.

Which competitive defenses are measured for Aclarion, Inc.?

The Corporate Default template measures 6 defenses, and ACONW scores: Pricing Power (6), Cost Advantage (3), Customer Stickiness (15), Capital Efficiency (8), Resilience (47), Scale & Market Position (7). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000